Home-Based Cardiac Rehabilitation for Heart Failure
This study is testing a home-based cardiac rehabilitation (HBCR) program for people with heart failure. Many people with heart failure don't participate in traditional, center-based rehabilitation. This program uses a special app and digital tools to provide education, counseling on healthy living, mindfulness, and physical activity guidance, with video calls from an exercise physiologist. You may be able to join if you are 18 or older, have Stage C heart failure (NYHA Class I-III), and have recently been hospitalized for heart failure or have certain scores on a heart failure questionnaire (KCCQ-SS <75). The study will look at how much physical activity participants do each day, measured at 12 weeks after starting the program. The current recruitment status is unclear.
- Study design
- This is a pilot randomized controlled trial with 100 planned participants. Participants will be assigned to either a control group or the HBCR mobile health intervention group.
- What's involved
- Participants will wear an actigraphy device for about one week to measure activity. The primary comparison of activity levels will be at 12 weeks after randomization.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured at 12 weeks after randomization.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
At a glance
Conditions
NCT06479876
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Vanderbilt University Medical Center
Nashville, Tennesseeno site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Brian R Lindman, MD, MSCI · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Average daily total activity countsThe actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily total activity counts determined. The primary comparison will be at 12 weeks after randomization.
Daily total activity counts are determined by a triaxial actigraphy device.